期刊文献+

成纤维细胞生长因子-21表达变化对3T3-L1脂肪细胞成纤维细胞生长因子受体及脂肪细胞因子的影响 被引量:2

The effects of fibroblast growth factor-21(FGF-21) on FGF receptors and adipokines in 3T3-L1 adipocytes
下载PDF
导出
摘要 目的探讨FGF-21表达变化对FGF相关受体(FGFRs)和脂肪细胞因子表达的影响。方法设计并构建2条针对小鼠FGF-21基因的短发夹状RNA(shRNA)序列,运用双荧光蛋白检测系统初步验证其有效性,筛选出抑制有效的pGenesil-FGF21重组质粒,分别用FGF-21过表达质粒pcDNA-FGF21和FGF-21 RNAi表达载体pGenesil-FGF21转染3T3-L1脂肪细胞,采用荧光定量PCR法检测FGF-21、FGFRs、脂联素、Visfatin以及瘦素(Leptin)的mRNA表达水平。结果成功构建2条FGF-21-shRNA重组质粒。转染上述重组载体的细胞内,两组pGenesil-FGF21 GFP平均荧光强度/RFP平均荧光强度均低于阴性对照组(均P<0.05),且pGenesil-FGF21-1组更低。转染pcDNA-FGF21的3T3-L1脂肪细胞内FGF-21 mRNA表达明显增加(P<0.01),转染pGenesil-FGF21-1的细胞内FGF-21 mRNA表达降低77.8%(P<0.05)。FGF-21过表达的脂肪细胞内以β-klotho和FG-FR1 mRNA表达明显升高,而Leptin mRNA表达明显降低;而FGF-21表达缺陷时则相反(均P<0.05)。结论 FGF-21可能主要通过β-klotho和FG-FR1途径激活受体后信号系统,并且可能通过影响脂肪细胞因子表达从而对代谢发挥其调控作用。 Objective To investigate the effects of fibroblast growth factor-21 (FGF-21) on fibroblast growth factor receptors ( FG- FR) and adipokines in 3T3-LI adipocytes. Methods Two shRNA motifs targeting on FGF-21 gene were designed and synthesized respectively. The effective shRNA-vector, pGenesil-FGF-21 were verified by double-fluorescence reporter assay system. The two vectors, pcDNA- FGF21 for over-expression and pGenesil-FGF21 for low-expression were transfeeted into 3T3-L1 adipocytes. The mRNA expressions of FGF- 21, FGFRs, adiponectin, visfatin and Leptin were detected by real-time quantitative PCR. Results The FGF21-shRNA vectors were constructed successfully. Fluorescence ratio of GFP/RFP in both groups were lower than that in HK group ( both P 〈0. 05 ). And the lowest was in pGenesil-FGF21-1 group. The transfeetion of pcDNA-FGF21 significantly increased FGF-21 mRNA expression in adipocytes ( P 〈0. 01 ). However, FGF-21 expression was down-regulated by 77.8% with transfection of pGenesil-FGF21 in adipocytes ( P 〈 0. 05 ). The mRNA ex- pressions of β-klotho and FGFRI were markedly increased in the adipocytes of FGF-21 over-expression ( both P 〈 0. 05 ). Meanwhile, the down-regulation of leptin was also observed in these adipocytes (P 〈 0. 05 ). The reverse changes happened in adipocytes with FGF-21 expressions deficient ( both P 〈0. 05 ). But the mRNA expressions of visfatin and adiponectin had no differences in these adipocytes. Conclusions In 3T3-L1 adipocytes, activating FGF-21 signaling downstream may be mainly through β-klotho and FGFR1, and FGF-21 to play an important role in metabolic homeostasis by accommodating some adipokines.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第6期968-971,共4页 Chinese Journal of Gerontology
基金 国家自然科学基金项目(30771037 30871199 30971388)
关键词 成纤维细胞因子-21 RNA干扰 FGF相关受体 脂肪细胞因子 Fibroblast growth factor-21 RNA interferences FGF related receptors Adipokines
  • 相关文献

参考文献9

  • 1Kharitonenkov A, Shiyanoya TL, Koester A, et al. FGF-21 as a novel metabolic regulator[J]. J Clin Invest,2005 ; 115 : 1627-35.
  • 2Coskun T, Bina HA, Schneider MA, et al. Fibroblast growth factor 21 corrects obesity in mice[J]. Endocrinology,2008 ; 149 : 6018-27.
  • 3Reynolds A, Leake D, Boese Q, et al. Rational siRNA design for RNA Interference[J]. Nat Bioteehno1,2004 ;22:326-30.
  • 4Ogawa Y, Kurosu H, Yamamoto M, et al. βKlotho is required for metabolic activity of fibroblast growth factor 21 [J]. Proc Natl Acad Sci U. S. A, 2007 ; 104:7432-7.
  • 5Moyers JS, Shiyanova TL, Mehrbod F, et al. Molecular determinants ofFGF-21 activity-synergy and cross-talk with PPAR Signaling [J]. J Cell Physio1,2007 ;210 : 1-6.
  • 6Kurosu H, Ogawa Y, Miyoshi M, et al. Regulation of fibroblast growth factor-23 signaling by klotho[J]. J Biol Chem,2006 ;281 : 6120-3.
  • 7Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23 [J]. Nature,2006 ;444:770-4.
  • 8Ito S, Kinoshia S, Shiraishi N, et al. Molecular cloning and expression analyse of mouse βklotho, which encodes a novel Klotho family protein [J]. Mech Dev,2000 ;98 : 115-9.
  • 9李伶,杨刚毅.脂代谢紊乱和脂肪细胞因子与胰岛素抵抗[J].中国糖尿病杂志,2007,15(3):129-131. 被引量:41

二级参考文献22

  • 1McGarry JD.Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.Diabetes,2001,50(suppl 2):6-7.
  • 2Taskinen MR.Diabetic dyslipidaemia:from basic research to clinical practice.Diabetologia,2003,46:733-743.
  • 3Zammit VA,Waterman IJ,Topping D,et al.Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance.J Nutr,2001,131:2074-2077.
  • 4Adiels M,Olofsson SO,Taskinen MR,et al.Diabetic dyslipidaemia.Curr Opin Lipidol,2006,17:238-246.
  • 5Heine RJ,Dekker JM.Beyond postprandial hyperglycaemia:metabolic factors associated with cardiovascular disease.Diabetologia,2002,45:461-475.
  • 6Johanson EH,Jansson PA,Gustafson B,et al.Early alterations in the postprandial VLDL1 apoB-100 and apoB-48 metabolism in men with strong heredity for type 2 diabetes,2004,255:273-279.
  • 7Kazumi T,Vranic M,Steiner G.Triglyceride kinetics:effects of dietary glucose,sucrose,or fructose alone or with hyperinsulinemia.Am J Physiol,1986,250:E325-330.
  • 8Parks EJ,Hellerstein MK.Carbohydrate-induced hypertriacylglycerolemia:historical perspective and review of biological mechanisms.Am J Clin Nutr,2000,71:412-433.
  • 9Fried SK,Rao SP,Sugars F.hypertriglyceridemia,and cardiovascular disease.Am J Clin Nutr,2003,78:873S-880S.
  • 10Adiels M,Boren J,Caslake MJ,et al.Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia.Arterioscler Thromb Vasc Biol,2005,25:1697-1703.

共引文献40

同被引文献11

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部